Important safety note Like GLP-1 receptor agonists, CagriSema is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Contraindications Based on mechanism of action and conservative interpretation of potential risks, BPC-157 use is generally discouraged in individuals with active or recent cancer, pregnancy or breastfeeding, autoimmune conditions with active flares, children and adolescents (unknown effects on development), and known hypersensitivity to any peptide compounds
It promotes soft tissue repair, which is crucial if you experience stiffness or tightness in your back
Reusing syringes or needles is one of the fastest ways to introduce contamination from one vial to another or from the environment into your BAC water
This quick absorption can be very helpful for peptides that need to function quickly or precisely when needed
The hardest advice for active people to follow is reducing training intensity during recovery
